Stocks360

AFT Pharmaceuticals Limited (AFT.NZ)

Stock analysis · NZE · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.47
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

AFT Pharmaceuticals Limited (AFT.NZ) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Nov 23, 2023
EPS $0.01 vs est. $0.03
Missed by $0.02

Proprietary Signals

Signal snapshot temporarily unavailable.

About AFT Pharmaceuticals Limited

AFT Pharmaceuticals, along with its subsidiaries, focuses on the creation and distribution of pharmaceutical products across New Zealand, Australia, Asia, and other global markets. Their extensive product range addresses a variety of health categories, including but not limited to allergy relief, cold and flu remedies, digestive health, eye care, first aid essentials, nail and oral care, pain management, skincare solutions, and nutritional supplements. This company was established in 1997 and its main office is located in Auckland, New Zealand.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap